Author

A. Akdoğan

Institution: Hacettepe University

Observed institution: Hacettepe University

OpenAlex ID: A5007124777

SAT0594 Which one is more valuable for diagnosis of adult onset still's disease? solely neutrophilia or leukocytosis with neutrophilia?

2018 · E. Bilgin, A. Erden, et al. · Annals of the Rheumatic Diseases · 4

POS0119 DIFFERENCES IN THE CHARACTERISTICS OF DIFFICULT-TO-MANAGE AXIAL SPONDYLOARTHRITIS (D2M-AxSpA) PATIENTS AT b/tsDMARD INITIATION

2025 · M.Ç. Akdemir, M. Ekici, et al. · Annals of the Rheumatic Diseases · 2

THU0433 The prevalence of spondyloarthropathy in patients with takayasu arteritis

2018 · S. Güzel, B. Armağan, et al. · Annals of the Rheumatic Diseases · 2

AB0278 IN RHEUMATOID ARTHRITIS PATIENTS RECEIVING bDMARDs, THE CHARLSON COMORBIDITY INDEX IS MORE PRONOUNCED THAN PSORIATIC ARTHRITIS

2022 · G. Sandal Uzun, O.D. Tatar, et al. · Annals of the Rheumatic Diseases · 1

Ab0282 Comorbidities Are More Important Than Jak Inhibitors: Venous Thromboembolism in Rheumatoid Arthritis

2022 · G. Sandal Uzun, M. Bahap, et al. · Annals of the Rheumatic Diseases · 1

Abs0981 Temporal Changes in Difficult-to-treat Rheumatoid Arthritis: When and Based on What Criteria

2025 · G.S. Kart Bayram, A. Eken, et al. · Annals of the Rheumatic Diseases

Ab0056 Radiological Evaluation of Pulmonary Artery Thrombosis in Patients With Behcet’s Disease

2024 · S.A. Germe, Z. Özsoy, et al. · Annals of the Rheumatic Diseases

Pos0991 Predictors of Development of Advanced Spinal Ankylosis/bamboo Spine in Axial Spondyloarthritis: Results From Real-life Data

2022 · B. Farisogullari, G.K. Yardimci, et al. · Annals of the Rheumatic Diseases

Ab0843 Osteoporosis in Patients With Spondyloarthritis: Do We Need to Do More?

2022 · Z. Özsoy, K. Moral, et al. · Annals of the Rheumatic Diseases

AB0353 bDMARD CHOICES FOR INFLAMMATORY ARTHRITIS WITH CHRONIC KIDNEY DISEASE; HUR-BIO REAL-LIFE REGISTRY

2022 · G. Sandal Uzun, A. Taghiyeva, et al. · Annals of the Rheumatic Diseases

Pos1440 Hematological Malignancies and Anti-tnf in Inflammatory Arthritis: the Real Life Data From the Hur-bio Registry

2022 · E. Duran, Z.Ö. Öztürk, et al. · Annals of the Rheumatic Diseases

AB0277 DYSLIPIDEMIA TREATMENT IN RHEUMATOID ARTHRITIS PATIENTS USING bDMARDs IS BETTER THAN PsA, BUT THERE IS STILL A WAY TO GO

2022 · G. Sandal Uzun, O.D. Tatar, et al. · Annals of the Rheumatic Diseases

Works count: 12

Citation count: 10

H-index: 2

I10-index: